Bavarian Nordic postpones IPO
A sour biotech market in the States has led Denmark’s Bavarian Nordic to postpone its IPO of American Depositary Shares on the Nasdaq exchange.
BY STEFAN SINGH KAILAY
Bavarian Nordic has opted to postpone its planned listing of American Depositary Shares (ADS), announced last month. The IPO could have been launched in late January, but a harsh beginning to the year for stock markets in the US in general and the biotech sector in particular has led the Denmark-based company to hold off on its plans.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
Få fuld adgang til dig og dine kollegaer
Start et gratis virksomhedsprøveabonnementRelaterede artikler
Bavarian will use IPO money to go it alone
For abonnenter
Bavarian wins major American Ebola contract
For abonnenter
Confident Bavarian hires new execs in-house
For abonnenter
